Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

IL-4/IL-13 Dual Cytokine Signaling in Severe Asthma: Mechanistic Insights by Prof. Kenneth Chapman

Recognizing the key cytokines driving type 2 inflammation and understanding their profound impact on patients’ asthma burden is crucial.1-3

GOLD 2026 Report: Key Updates for COPD Management

What’s New in the GOLD 2026 Report

Understanding Kaplan–Meier Curves in MS: An Overview with Dr. Barry Singer

Understanding 6‑Month CDP in MS: An Overview with Dr. Barry Singer

Understanding PIRA in MS: An Overview with Dr. Barry Singer

ODYSSEY data mining

ACS EuroPath Survey

IL-4, IL-13, AND IL-5 ARE DRIVERS OF SYSTEMIC TYPE 2 INFLAMMATION

Eosinophilic inflammation has multiple drivers1,2

Managing dyslipidemia in your ASCVD patients according to the new guidelines

The pathophysiology of ITP stems from complex immune dysregulation drives thrombocytopenia and inflammation

Rilzabrutinib a BTK inhibitor

Complex immune dysregulation impact on QoL